ArticleFrontiers in nutrition2025
Global, regional, and national burden of gastric cancer attributable to diet high in sodium from 1990 to 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Burden of Mesothelioma in China, 1990-2023: Trends, Decomposition, and Projections Until 2045.Cancers · 2026Article
- Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023.Cancers · 2026Article
- Global, regional and national burden of colorectal cancer attributable to low-fiber diet from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.Frontiers in nutrition · 2026Article
- Temporal Trends and Future Projections of Oral Disorders Among Women of Childbearing Age in South Korea.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study, based on the Global Burden of Disease (GBD) 2021 database, investigates the global and regional burden of gastric cancer attributable to diet high in sodium (GC-DHIS) from 1990 to 2021 and projects trends through 2045, with the aim of providing evidence to inform public health policymaking. Methods: Data were obtained from GBD 2021, covering 204 countries and territories. Disability-adjusted life years (DALYs) were used as the primary metric. The Das Gupta method was applied to decompose the drivers of changes in disease burden, and the Nordpred model was used to forecast future trends. Results: Between 1990 and 2021, the global number of DALYs attributable to GC-DHIS decreased by 2%, while deaths increased by 12%. The largest absolute number of DALYs was observed in middle SDI regions, whereas the most rapid growth occurred in low-middle SDI regions. Health inequality analysis revealed that the burden of GC-DHIS was disproportionately concentrated in regions with higher levels of social development. Projections from 2022 to 2045 suggest a significant increase in DALYs and deaths, with a faster rise among males. However, age-standardized DALY rates (ASDR) and age-standardized mortality rates (ASMR) are expected to decline substantially. Conclusion: Despite the global decline in ASDR and ASMR of GC-DHIS, the absolute burden is expected to rise in specific regions and populations, highlighting the need for targeted prevention and control strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.